NCT07371312 Outcomes of Couples After Failed PGD Management: A Single-Center Study at the Paris PGD Center (Antoine Béclère - Necker)
| NCT ID | NCT07371312 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Infertility |
| Study Type | OBSERVATIONAL |
| Enrollment | 900 participants |
| Start Date | 2026-03-25 |
| Primary Completion | 2028-03-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 900 participants in total. It began in 2026-03-25 with a primary completion date of 2028-03-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Preimplantation genetic testing (PGT) is a reproductive genetic technique aimed at preventing the transmission of severe genetic disorders. In France, its use is strictly regulated and reserved for complex medical situations, often associated with challenging reproductive histories and significant psychological burden. Despite scientific advances, success rates in preimplantation genetic testing remain limited, making the care pathway a significant source of uncertainty regarding the future of the parental project.
Eligibility Criteria
Inclusion Criteria: * Woman belonging to a couple who initiated at least one ovarian stimulation cycle for IVF (± ICSI) with preimplantation genetic diagnosis (PGD). * No further PGD-related procedures (oocyte retrieval or embryo transfer) performed in the center after December 31, 2022. * No live-born child resulting from PGD care. * Woman who expressed her free and informed non-opposition to participation. Exclusion Criteria: * One or more live-born children resulting from PGD care in the center. * PGD involving gamete donation.
Contact & Investigator
Charlotte SONIGO, PhD
PRINCIPAL INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT07371312 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07371312 currently recruiting?
Yes, NCT07371312 is actively recruiting participants. Contact the research team at charlotte.sonigo@aphp.fr for enrollment information.
Where is the NCT07371312 trial being conducted?
This trial is being conducted at Clamart, France.
Who is sponsoring the NCT07371312 clinical trial?
NCT07371312 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Charlotte SONIGO, PhD at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 900 participants.